CHELSEA WELLS: Open Payments
NPI 1861914699 · BELMONT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$159 in 9 payments from 4 companies in 2025. Trend: 2023 $159 · 2024 $218 · 2025 $159
Food & beverage: $159
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $86 |
| Novo Nordisk Inc | 2 | $31 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Galderma Laboratories, L.P. | 1 | $16 |
Products named: VRAYLAR, Auvelity, QULIPTA, UBRELVY, Ozempic, Rybelsus.
Industry payments across MS — which companies pay providers there.
